On March 27, the firm presented “DOJ and HHS-OIG Developments,” the first program of Skadden’s annual Pharmaceutical and Medical Device Webinar Series. Firm speakers included Washington, D.C. life sciences and health care partner Avia Dunn, Boston partner Maya Florence and Chicago litigation partner John Kocoras. The panelists discussed the DOJ’s activity in 2023 and predictions for 2024, recent DOJ enforcement trends and HHS-OIG compliance-related activities, DOJ theories of liability, cases involving individual life sciences executives, and what life sciences companies should know about the HHS-OIG General Compliance Program Guidance and recent advisory opinions.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates